Drugs
Home Page
Xagena Medicine
Xagena.net
Oseltamivir prescribed concurrently with Warfarin: suspected increase in INR
Antidepressants linked to increased risk of persistent pulmonary hypertension in newborns
Pregnancy: newer antidepressants linked to persistent pulmonary hypertension in newborns
Reminyl appears to protect against nerve agents
Daytrana to treat attention deficit hyperactivity disorder in children, FDA approved
Heart transplant: Prograf to prevent rejection, FDA approved
Head and neck tumor: treatment with Cetuximab extends survival
FDA: Selegiline is the first transdermal patch for depression
Naltrexone extended-release for treatment of alcohol-dependent patients, FDA approved
Pegaptanib: rare cases of anaphylaxis or anaphylactoid reactions
Sepsis associated with Mifepristone for medical abortion
Gatifloxacin associated with hypoglycemia and hyperglycemia
Bosentan linked to hepatotoxity
Meloxicam linked to higher risk of adverse cardiovascular events than Celecoxib and Rofecoxib
Antidepressants: increased risk of suicidal behavior in young adults for Paxil
Smoking cessation: FDA has approved Chantix
Parkinson's disease: Azilect approved from FDA
Postmenopausal women at increased risk for cardiovascular disease: Raloxifene associated with increased risk of stroke mortality
Ranexa for chronic angina, FDA approved
FDA: prophylaxis indication for Tamiflu to children between 1 to 12 years of age
Cancer: hearing loss from chemotherapy underestimated
Beethoven suffered from a toxic overload of lead
Some patients who receive an appropriate level of Morphine live a little longer
Paracetamol poisoning, the most common cause of acute liver failure in the United States
Increased risk for diarrhea infection with use of gastric acid-suppressive agents
iNOS-based inflammation pathway is cross-linked with COX-2 pathway
Epoetin alfa: reports of pure red cell aplasia and severe anemia associated with neutralizing antibodies to erythropoietin
Elderly, non-hemophiliac, intracerebral hemorrhage patients: NovoSeven increases risk of arterial thromboembolic events
Risk of birth defects with Paroxetine
Three myocardial infarctions with Vioxx were not included in VIGOR study
Next Pages
1
2
3
4
5
6
7
[
8
]
9
10
Web
Xagena News
Link
•
Allergology
•
Andrology
•
Biomedicine
•
Cardiology
•
Dermatology
•
Diabetology
•
Diagnostics
•
Drugs
•
Endocrinology
•
Gastroenterology
•
Gene Medicine
•
Gynecology
•
Hematology
•
Hepatology
•
Infectivology
•
Metabolism
•
Nephrology
•
Neurology
•
Oncology
•
Ophthalmology
•
Pediatrics
•
Pharmacology
•
Pneumology
•
Psychiatry
•
Rheumatology
•
Stem Therapy
•
Urology
•
Vaccines
•
Virology
n
Xagena.it
Powered by Luca Malattia -
LM Web Solutions